−28.25USD
−12.32 MUSD
250.00 KUSD
836.48 K
About Palisade Bio, Inc.
Sector
CEO
J. D. Finley
Headquarters
Carlsbad
Website
Employees (FY)
9
Founded
2011
FIGI
BBG000QG4DJ2
Palisade Bio, Inc. is a biopharmaceutical company, which engages in the development of oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. It offers LB1148, an oral formulation of a broad-spectrum serine protease inhibitor designed to neutralize the activity of potent digestive proteases released from the gut during surgery. The company was founded on September 6, 2011 and is headquartered in Carlsbad, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PALI is 5.94 USD — it has increased by 20.40% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Palisade Bio, Inc. stocks are traded under the ticker PALI.
Palisade Bio, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
PALI stock is 57.14% volatile and has beta coefficient of 1.28. Check out the list of the most volatile stocks — is Palisade Bio, Inc. there?
PALI earnings for the last quarter are −7.35 USD per share, whereas the estimation was −5.93 USD resulting in a −24.05% surprise. The estimated earnings for the next quarter are −5.19 USD per share. See more details about Palisade Bio, Inc. earnings.
Yes, you can track Palisade Bio, Inc. financials in yearly and quarterly reports right on TradingView.
PALI stock has fallen by 32.16% compared to the previous week, the month change is a 2.78% rise, over the last year Palisade Bio, Inc. has showed a 77.26% decrease.
PALI net income for the last quarter is −2.97 M USD, while the quarter before that showed −3.61 M USD of net income which accounts for 17.75% change. Track more Palisade Bio, Inc. financial stats to get the full picture.
Today Palisade Bio, Inc. has the market capitalization of 4.20 M, it has decreased by 29.25% over the last week.
No, PALI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PALI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Palisade Bio, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 23, 2024, the company has 9.00 employees. See our rating of the largest employees — is Palisade Bio, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Palisade Bio, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Palisade Bio, Inc. stock shows the sell signal. See more of Palisade Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Palisade Bio, Inc. future price: according to them, PALI price has a max estimate of 22.50 USD and a min estimate of 22.50 USD. Read a more detailed Palisade Bio, Inc. forecast: see what analysts think of Palisade Bio, Inc. and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Palisade Bio, Inc. EBITDA is −12.79 M USD, and current EBITDA margin is −5.14 K%. See more stats in Palisade Bio, Inc. financial statements.